The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients.

The streptococcal fibrinolytic principle (streptokinase) has been demonstrated to be an effective agent, in vivo, in patients as a means of mediating the relatively rapid liquefaction of extravascular fibrin coagulums (1). Streptokinase (referred to in this article as SK) has also been shown to be useful as a therapeutic reagent, by which massive extravascular clots may be eradicated by liquefaction and aspiration (2). These findings have received extensive confirmation. (See Footnote 12 to the list of References.) It is the purpose of this article to describe the results of studies of the intravenous administration of SK into patients. The ultimate objective of the study is directed toward attempting to determine whether or not clots occurring within the vascular system as a result of disease may be subject to

[1]  S. Sherry,et al.  The enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators. , 1954, The Journal of clinical investigation.

[2]  S. Sherry.  The fibrinolytic activity of streptokinase activated human plasmin. , 1954, The Journal of clinical investigation.

[3]  C. Grossi,et al.  LYSIS OF THROMBI PRODUCED BY SODIUM MORRHUATE IN THE FEMORAL VEIN OF DOGS BY HUMAN PLASMIN (FIBRINOLYSIN) , 1954, Annals of surgery.

[4]  C. Grossi,et al.  In vivo studies of human plasmin; intravenous injection in dogs and rabbits. , 1953, Journal of applied physiology.

[5]  O. Ratnoff,et al.  THE INACTIVATION OF COMPLEMENT AND ITS COMPONENTS BY PLASMIN , 1953, The Journal of experimental medicine.

[6]  W. Tillett,et al.  THE LYSIS IN RABBITS OF INTRAVASCULAR BLOOD CLOTS BY THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM (STREPTOKINASE) , 1952, The Journal of experimental medicine.

[7]  W. Hubbard.  The systemic toxic responses of patients to treatment with streptokinase streptodornase. , 1951, The Journal of clinical investigation.

[8]  O. Ratnoff,et al.  A new method for the determination of fibrinogen in small samples of plasma. , 1951, The Journal of laboratory and clinical medicine.

[9]  M. Weiner,et al.  A simply prepared, standardized, and relatively stable thromboplastin extract for estimation of prothrombin time. , 1950, American heart journal.

[10]  W. Tillett,et al.  The use of streptokinase-streptodornase in the treatment of hemothorax. , 1950, The Journal of thoracic surgery.

[11]  E. Fischel,et al.  SEROLOGICAL STUDIES IN RHEUMATIC FEVER. II. SERUM COMPLEMENT IN THE RHEUMATIC STATE. , 1949, The Journal of clinical investigation.

[12]  L. R. Christensen,et al.  METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE. , 1949, The Journal of clinical investigation.

[13]  M. Guest,et al.  Fibrinogen; with special reference to its preparation and certain properties of the product. , 1947, Archives of biochemistry.

[14]  F. Yonkman,et al.  Pharmacodynamic studies of a new antihistamine agent, N'-pyridyl-N benzyl-N-dimethylethylene diamine HCI, pyribenzamine HCI; effects on salivation, nictitating membrane, lachrymation, pupil and blood pressure. , 1946, The Journal of pharmacology and experimental therapeutics.

[15]  W. Goldring,et al.  HEMODYNAMIC ALTERATIONS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS DURING THE PYROGENIC REACTION. , 1945, The Journal of clinical investigation.

[16]  W. Tillett,et al.  BIOCHEMICAL STUDIES ON THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI , 1934, The Journal of experimental medicine.